BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1285330)

  • 21. [The relations between Hodgkin's and non-Hodgkin's lymphoma].
    Lennert K
    Arzneimittelforschung; 1987 Feb; 37(2A):255-9. PubMed ID: 3566873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis versus lymphomas in the abdominal lymph nodes: evaluation with contrast-enhanced CT.
    Yang ZG; Min PQ; Sone S; He ZY; Liao ZY; Zhou XP; Yang GQ; Silverman PM
    AJR Am J Roentgenol; 1999 Mar; 172(3):619-23. PubMed ID: 10063847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphomas in Iran.
    Hashemi-Bahremani M; Parwaresch MR; Tabrizchi H; Gupta RK; Raffii MR
    Arch Iran Med; 2007 Jul; 10(3):343-8. PubMed ID: 17604472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eosinophilia and plasmacytosis of the bone marrow in Hodgkin's disease.
    Kass L; Votaw ML
    Am J Clin Pathol; 1975 Aug; 64(2):248-50. PubMed ID: 1155387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lymphoid infiltrates in the lung].
    Szalontai K; Krenács L; Csanádi J; Ugocsai K; Kraszkó P
    Orv Hetil; 1993 Nov; 134(45):2473-6. PubMed ID: 8247513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour imaging of indium-111 oxine-labelled autologous lymphocytes as a staging method in Hodgkin's disease.
    Grimfors G; Schnell PO; Holm G; Johansson B; Mellstedt H; Pihlstedt P; Björkholm M
    Eur J Haematol; 1989 Mar; 42(3):276-83. PubMed ID: 2494057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallium-67 scintiscan in the diagnosis of primary splenic non-Hodgkin's lymphoma after the treatment of Hodgkin's disease.
    Lee JD; Park CH; Griffith J; Vernick J
    J Nucl Med; 1992 Jun; 33(6):1183-5. PubMed ID: 1597736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone marrow biopsies and Hodgkin's disease].
    Pris J; Fabre J; Corberand J; Vincent F; Delsol G; Monnier J; Bierme R
    Nouv Rev Fr Hematol; 1973; 13(3):410-5. PubMed ID: 4270597
    [No Abstract]   [Full Text] [Related]  

  • 30. Tissue and plasma lysozyme in Hodgkin's disease.
    Hansen NE; Clausen PP; Karle H; Christoffersen P
    Scand J Haematol; 1981 Sep; 27(3):186-92. PubMed ID: 7313545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal involvement of malignant lymphoma in the liver.
    Görg C; Schwerk WB; Görg K; Havemann K
    Bildgebung; 1991; 58(2):67-70. PubMed ID: 1912716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
    Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
    Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin analogue scintigraphy of malignant lymphomas.
    Vanhagen PM; Krenning EP; Reubi JC; Mulder AH; Bakker WH; Oei HY; Löwenberg B; Lamberts SW
    Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies.
    Bucerius J; Herkel C; Joe AY; Altehoefer C; Finke J; Moser E; Reinhardt MJ
    Nuklearmedizin; 2006; 45(3):105-10; quiz N25-6. PubMed ID: 16710505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
    Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
    J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease complicating non-Hodgkin's lymphoma.
    Shumak SL; Srigley J; Rusthoven J; Cowan DH
    CMAJ; 1988 Dec; 139(12):1157-9. PubMed ID: 3196987
    [No Abstract]   [Full Text] [Related]  

  • 38. The histology of the initial relapse of Hodgkin's disease.
    Colby TV; Warnke RA
    Cancer; 1980 Jan; 45(2):289-92. PubMed ID: 7351011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Computerized tomography diagnosis of lymphadenopathies in malignant non-Hodgkin's lymphomas].
    Cheremisin VM; Mazurov VI; Anosov NA; Savello VE; Belov AF; Novik AA; Mel'nichenko VIa; Nikolaevich MS
    Vestn Rentgenol Radiol; 1996; (6):5-10. PubMed ID: 9027080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.